
Dr Cheong Wai Kwong
Senior Consultant Dermatologist

Psoriasis is an immune-mediated inflammatory skin disorder. The underlying immune dysfunction is thought to result from the complex interplay between genetic and environmental factors.
Some patients with psoriasis may have a family member who is also affected with psoriasis. A flare-up of psoriasis can be triggered by stress, injury to the skin, infections, and certain medications. Psoriasis has also been found to be associated with heart disease and diabetes mellitus.
The most common indication is the presence of raised, red patches (plaques) on the skin, covered with silvery or white scales, primarily appearing on the elbows, knees, scalp, lower back, feet, nails, and genital regions. Other signs and symptoms include:
The severity of symptoms can range from mild to severe, with some individuals experiencing occasional flare-ups while others have persistent symptoms.
For some patients, the inflammatory process underlying psoriasis can also affect the joints. This condition is called psoriatic arthritis and presents as painful, stiff joints.
There are several types of psoriasis, classified based on their distinctive appearance and symptoms.
Psoriasis can be mild, moderate or severe. Those patients with rashes covering less than 3% of their body are considered to have mild disease, those with 3–10% covered are considered moderate. These categories are useful for deciding which treatments may be most appropriate for the patient. However, other deciding factors in selecting treatments such as the impact of psoriasis on the quality of life need to be taken into consideration too.
Although psoriasis is not curable, several treatment options are available to effectively manage the disease. At Specialist Skin Clinic, we offer treatments for psoriasis that range from topical creams to phototherapy, with each plan tailored to the severity of the condition and the specific type of psoriasis.
For most individuals with mild psoriasis in Singapore, topical treatment is typically the first-line option. These medications are applied directly to the skin to reduce inflammation, slow excessive cell growth and relieve itching.
If topical treatments do not provide adequate control, phototherapy may be recommended as an adjunct. This involves exposing the skin to controlled doses of narrowband ultraviolet B (UVB) light to slow excessive cell growth and reduce inflammation. Sessions are usually conducted two to three times a week under specialist supervision.
For individuals with moderate to severe psoriasis, these treatments can help by calming the overactive immune response that drives inflammation in the skin. These medications can either be taken orally or by injection.
Biologic treatments or “biologics” are a new class of medication that has revolutionised psoriasis treatment. They are protein-based drugs derived from living cells in the laboratory and have been in use to treat psoriasis in the last decade. This class of medication offers hope to psoriasis patients who have failed other treatments or have experienced side effects from their previous treatments. These medications are given as injections via the subcutaneous or intravenous route and help to reduce the inflammatory process that is driving the replication of skin cells and the destruction of the joints.
In psoriasis, a protein in the immune system called tumour necrosis factor is known to be present at increased levels and this leads to inflammation. Tumour necrosis factor - alpha (TNF-α) inhibitors are a big group of biologics that bind to the excess TNF-α to decrease the inflammation process. Examples are Etanercept, Adalimumab and Infliximab. Another class of biologics works against interleukin 12/23 which are associated with psoriatic inflammation. An example of this class of biologics is Ustekinumab which specifically targets and blocks the action of IL-12 and IL-23.
The latest biologics that are available in Singapore are Secukinumab (Cosentyx®) and Ixekizumab (Taltz®). Guselkumab (Tremfya®) and Risankizumab (Skyrizi®). Secukinumab is a human monoclonal antibody that selectively binds to interleukin-17A (IL-17A). IL-17A is involved in the development of psoriasis. Ixekizumab is a humanised monoclonal antibody against IL-17A. Guselkumab is a human monoclonal antibody that binds to IL-23 with high specificity and affinity. Risankizumab is a humanised antibody against IL-23. All these biologics interrupt the inflammatory cycle of psoriasis leading to improvement of the condition.
These injections are all available in the clinic. Patients are assessed for their suitability for biologics based on their clinical history, concurrent medical issues, and lifestyle needs.
In addition to medical treatments, lifestyle changes and self-care measures can help improve symptoms and prevent psoriasis flare-ups. The following are some tips for managing psoriasis:
No, psoriasis is not contagious. The condition develops because of an internal immune response that affects how skin cells grow, not because of infection. You can interact normally with others without worrying about transmission.
Psoriasis is not curable, but many effective treatments can control symptoms and reduce flare ups. These treatments calm the overactive immune response and slow rapid skin cell growth. With the right plan guided by a specialist, most patients can achieve good long term control and improved skin comfort.
Psoriasis can increase your risk of developing other health problems, such as psoriatic arthritis, heart disease, and diabetes. This is because the inflammation involved affects the body beyond the skin. Regular medical review helps detect these issues early and supports long term personalised care to keep symptoms stable and overall health protected.
Psoriasis can run in families, so having a parent or sibling with the condition may increase your risk. Even so, not everyone with a family history will develop it. Other factors such as the immune system and the environment also play a role. A doctor can help explain your individual risk in clearer terms.

Senior Consultant Dermatologist

| Main Line | : (65) 6734 1411 |
| Fax | : (65) 6235 5900 |
| Mon - Fri | : 8:30am - 5:00pm |
| Sat | : 8:00am - 1:00pm |
| Closed on Sundays and Public Holidays | |